Nuclear Localization Signal and p53 Binding Site in MAP/ERK Kinase Kinase 1 (MEKK1)

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• Mekk1 interacts with tumor suppressor p53, co-repressing PKD1 transcription.
• Understanding Mekk1's nuclear transport and p53 binding is crucial for its function.

Purpose of the Study:

• To elucidate the mechanisms underlying Mekk1 nuclear transport.
• To identify the specific sequences in Mekk1 responsible for p53 binding.
• To investigate Mekk1's role in p53 protein stability and degradation.

Main Methods:

• Utilized GFP-linked constitutively active-Mekk1 (CA-Mekk1) with deletion strategies.
• Employed co-immunoprecipitation to identify protein interactions.
• Assessed nuclear translocation in HEK293T and COS-1 cells.
• Analyzed p53 phosphorylation and ubiquitination levels.

Main Results:

• Identified a nuclear localization signal (HRDVK) in Mekk1's C-terminal catalytic domain.
• Identified a p53 binding sequence (GANLID) adjacent to the NLS in Mekk1.
• Deletion of these sequences impaired nuclear translocation and p53 interaction.
• Mekk1 enhances p53 stability by reducing ubiquitination, independent of p53 Ser15 phosphorylation.
• Mekk1 interferes with Mdm2-mediated p53 degradation via the ubiquitin-proteasome pathway.

Conclusions:

• Mekk1 nuclear import is mediated by a specific NLS (HRDVK).
• Mekk1 binds p53 via an adjacent sequence (GANLID).
• Mekk1 stabilizes p53 by inhibiting Mdm2-dependent degradation, offering new insights into p53 regulation.